MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 05-23-2026
Genetic Technologies Limited EBITDA per Share 2011-2026 | GENE
Annual EBITDA per Share Genetic Technologies Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | -1.27 | -1.3 | -1.99 | -2.67 | -4.97 | -9.27 | -10.4 | -12.7 | 2.3 |
All numbers in AUD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.3 | -12.7 | -4.7 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B |  USA |
 |
Fulgent Genetics
FLGT
|
-2.18 | $ 17.67 | - | $ 544 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 119.85 | - | $ 15 B | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 113.85 | - | $ 9.39 B |  Irlanda |
 |
Agilent Technologies
A
|
5.49 | $ 115.08 | 0.02 % | $ 35 B | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.8 | -1.1 % | $ 7.96 M | USA |
 |
Celcuity
CELC
|
-3.68 | $ 134.26 | - | $ 6.28 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Illumina
ILMN
|
-3.01 | $ 145.23 | - | $ 23.1 B | USA |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 9.11 | - | $ 12.1 M | USA |
 |
Castle Biosciences
CSTL
|
-0.07 | $ 19.69 | - | $ 571 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 21.54 | - | $ 1.15 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 100.06 | - | $ 6.75 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 101.33 | - | $ 22.7 B |  Schweiz |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.27 | - | $ 1.19 B | USA |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
1.35 | $ 19.04 | -0.21 % | $ 426 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 200.91 | - | $ 19.8 B | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 156.73 | - | $ 7.77 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Personalis
PSNL
|
-0.87 | $ 8.94 | - | $ 798 M | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 429.11 | - | $ 12.4 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 3.85 | - | $ 357 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 26.94 | -0.06 % | $ 25.5 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 64.87 | - | $ 3.88 B | USA |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.43 | - | $ 268 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.47 | - | $ 5.67 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 258.45 | - | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 448.18 | - | $ 169 B | USA |
 |
Waters Corporation
WAT
|
6.02 | $ 338.64 | - | $ 20.2 B | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.65 | - | $ 233 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Exagen
XGN
|
-0.56 | $ 4.62 | - | $ 99.6 M | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.14 | - | $ 1.98 B | USA |